To evaluate the activation of T lymphocytes and NK cells to DC vaccination in vivo myeloma model, splenocytes from each group of vaccinated mice were prepared for IFN-γ ELISPOT assays. This evidence concerns the gene IFNG and plasma cell myeloma.